Clinical trial
A Double-blind, Placebo Controlled Study to Assess Efficacy of 5-Aminolevulinic Acid in Subjects With Iron Deficiency Anemia
NCT01380548 is registered in ClinicalTrials.gov with Hiroshima University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Placebo Controlled Study to Assess Efficacy of 5-Aminolevulinic Acid in Subjects With Iron Deficiency Anemia
- Lead sponsor
- Hiroshima University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- December 31, 2012
- Enrollment
- 135 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iron deficiency anemia